[시장보고서]반려동물 의약품 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 적응증별, 동물별, 유통 채널별, 지역별, 경쟁별 세분화(2020-2030년)

반려동물 의약품 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 적응증별, 동물별, 유통 채널별, 지역별, 경쟁별 세분화(2020-2030년)

Companion Animal Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Animal, By Distribution Channel, By Region and Competition, 2020-2030F

상품코드 : 1886392

리서치사 : TechSci Research

발행일 : 2025년 12월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,708,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,199,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,926,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 반려동물 의약품 시장은 2024년에 185억 2,000만 달러로 평가되며, 2030년까지 CAGR 9.25%로 성장하며, 314억 9,000만 달러에 달할 것으로 예측됩니다. 세계 반려동물 의약품 시장은 반려동물의 질병 치료, 예방 및 관리를 목적으로 개발된 의약품 및 생물제제(의약품, 백신, 보충제 포함)를 포괄합니다. 이 시장의 성장은 주로 반려동물 사육 수 증가, 반려동물의 인간화 추세로 인한 동물 의료비 증가, 예방 의료에 대한 보호자의 인식 증가, 수의학의 지속적인 발전 등에 의해 주도되고 있습니다.

시장 개요
예측 기간	2026-2030
시장 규모 : 2024년	185억 2,000만 달러
시장 규모 : 2030년	314억 9,000만 달러
CAGR : 2025-2030년	9.25%
가장 빠르게 성장하는 부문	피부 질환
최대 시장	북미

주요 시장 성장 촉진요인

세계 반려동물 사육 증가 추세와 반려동물의 인간화 추세가 맞물려 반려동물 의약품 시장의 기반이 되는 촉진요인이 되고 있습니다. 반려동물 보호자들은 반려동물을 가족의 일원으로 인식하는 경향이 강해지고 있으며, 반려동물의 건강과 행복을 위해 많은 투자를 하려는 의지가 강해지고 있습니다.

주요 시장 과제

세계 반려동물 의약품 시장 확대를 가로막는 가장 큰 문제는 연구개발에 소요되는 막대한 비용과 더불어 엄격한 규제 요건과 신규 동물용의약품의 승인 절차가 길어지고 있다는 점입니다. 이러한 요소들이 복합적으로 작용하여 지속적인 투자를 방해하고, 혁신적인 치료법 시장 진입을 지연시키며, 반려동물의 진화하는 건강 요구에 효과적으로 대응할 수 있는 업계의 능력에 영향을 미치고 있습니다.

주요 시장 동향

생물제제 및 첨단 치료법의 채택 확대는 기존의 저분자 의약품에서 보다 표적화된 치료법으로 전환하는 반려동물 의약품의 큰 진화를 보여주고 있습니다. 모노클로널 항체 및 유전자 치료제를 포함한 이러한 혁신적 치료법은 골관절염, 각종 암과 같은 만성 및 복합 질환의 관리에 있으며, 높은 효과와 정밀성을 제공합니다.

영문목차

The Global Companion Animal Pharmaceuticals Market, valued at USD 18.52 Billion in 2024, is projected to experience a CAGR of 9.25% to reach USD 31.49 Billion by 2030. The global companion animal pharmaceuticals market encompasses pharmaceutical and biological products developed to treat, prevent, and manage diseases in pets, including medications, vaccines, and supplements. This market's growth is primarily driven by increasing pet ownership, the notable trend of pet humanization leading to higher spending on animal health, rising awareness among owners regarding preventive care, and continuous advancements in veterinary medical science.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 18.52 Billion
Market Size 2030	USD 31.49 Billion
CAGR 2025-2030	9.25%
Fastest Growing Segment	Dermatologic Diseases
Largest Market	North America

Key Market Drivers

The increasing global trend of pet ownership coupled with the growing humanization of pets represents a foundational driver for the companion animal pharmaceuticals market. Pet owners increasingly view their animals as integral family members, leading to a willingness to invest significantly in their health and well-being. This shift elevates the standard of care provided to pets, encompassing advanced medical treatments, preventive medications, and specialized therapies.

Key Market Challenges

A significant challenging factor impeding the expansion of the Global Companion Animal Pharmaceuticals Market involves the substantial costs associated with research and development, compounded by stringent regulatory requirements and a protracted approval process for new veterinary drugs. These elements collectively deter sustained investment and prolong the market entry of innovative treatments, thereby impacting the industry's capacity to effectively address the evolving health needs of companion animals. This extended development pipeline can delay critical advancements in medications, vaccines, and supplements.

Key Market Trends

The growing adoption of biologics and advanced therapeutics signifies a profound evolution in companion animal pharmaceuticals, moving beyond traditional small-molecule drugs to more targeted interventions. These innovative treatments, including monoclonal antibodies and gene therapies, offer enhanced efficacy and precision in managing chronic and complex diseases, such as osteoarthritis and various cancers. Their ability to address unmet medical needs by targeting specific disease pathways is driving demand.

Key Market Players

Zoetis Services LLC
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Virbac Taiwan Co., Ltd.
Vetoquinol S.A.
Dechra Pharmaceuticals Limited
Chanelle Pharma
KyoritsuSeiyaku Corporation

Report Scope:

In this report, the Global Companion Animal Pharmaceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Pharmaceuticals Market, By Indication:

Infectious diseases
Dermatologic diseases
Pain
Orthopedic diseases
Behavioural diseases
Other

Companion Animal Pharmaceuticals Market, By Animal:

Dogs
Cats
Horses
Other

Companion Animal Pharmaceuticals Market, By Distribution Channel:

Veterinary hospitals and clinics
Retail pharmacies
Others

Companion Animal Pharmaceuticals Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Companion Animal Pharmaceuticals Market.

Available Customizations:

Global Companion Animal Pharmaceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Companion Animal Pharmaceuticals Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Indication (Infectious diseases, Dermatologic diseases, Pain, Orthopedic diseases, Behavioural diseases, Other)
- 5.2.2. By Animal (Dogs, Cats, Horses, Other)
- 5.2.3. By Distribution Channel (Veterinary hospitals and clinics, Retail pharmacies, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Companion Animal Pharmaceuticals Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Indication
- 6.2.2. By Animal
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Companion Animal Pharmaceuticals Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Indication
    - 6.3.1.2.2. By Animal
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Companion Animal Pharmaceuticals Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Indication
    - 6.3.2.2.2. By Animal
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Companion Animal Pharmaceuticals Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Indication
    - 6.3.3.2.2. By Animal
    - 6.3.3.2.3. By Distribution Channel

7. Europe Companion Animal Pharmaceuticals Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Indication
- 7.2.2. By Animal
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Companion Animal Pharmaceuticals Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Indication
    - 7.3.1.2.2. By Animal
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. France Companion Animal Pharmaceuticals Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Indication
    - 7.3.2.2.2. By Animal
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. United Kingdom Companion Animal Pharmaceuticals Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Indication
    - 7.3.3.2.2. By Animal
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. Italy Companion Animal Pharmaceuticals Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Indication
    - 7.3.4.2.2. By Animal
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Companion Animal Pharmaceuticals Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Indication
    - 7.3.5.2.2. By Animal
    - 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Companion Animal Pharmaceuticals Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Indication
- 8.2.2. By Animal
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Companion Animal Pharmaceuticals Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Indication
    - 8.3.1.2.2. By Animal
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Companion Animal Pharmaceuticals Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Indication
    - 8.3.2.2.2. By Animal
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Companion Animal Pharmaceuticals Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Indication
    - 8.3.3.2.2. By Animal
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Companion Animal Pharmaceuticals Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Indication
    - 8.3.4.2.2. By Animal
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Companion Animal Pharmaceuticals Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Indication
    - 8.3.5.2.2. By Animal
    - 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Companion Animal Pharmaceuticals Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Indication
- 9.2.2. By Animal
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Companion Animal Pharmaceuticals Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Indication
    - 9.3.1.2.2. By Animal
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. UAE Companion Animal Pharmaceuticals Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Indication
    - 9.3.2.2.2. By Animal
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. South Africa Companion Animal Pharmaceuticals Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Indication
    - 9.3.3.2.2. By Animal
    - 9.3.3.2.3. By Distribution Channel

10. South America Companion Animal Pharmaceuticals Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Indication
- 10.2.2. By Animal
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Companion Animal Pharmaceuticals Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Indication
    - 10.3.1.2.2. By Animal
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Colombia Companion Animal Pharmaceuticals Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Indication
    - 10.3.2.2.2. By Animal
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. Argentina Companion Animal Pharmaceuticals Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Indication
    - 10.3.3.2.2. By Animal
    - 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Companion Animal Pharmaceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zoetis Services LLC
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Merck & Co., Inc.
15.3. Boehringer Ingelheim International GmbH
15.4. Elanco Animal Health Incorporated
15.5. Virbac Taiwan Co., Ltd.
15.6. Vetoquinol S.A.
15.7. Dechra Pharmaceuticals Limited
15.8. Chanelle Pharma
15.9. KyoritsuSeiyaku Corporation

한글목차

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 반려동물 의약품 시장 전망

제6장 북미의 반려동물 의약품 시장 전망

제7장 유럽의 반려동물 의약품 시장 전망

제8장 아시아태평양의 반려동물 의약품 시장 전망

제9장 중동 및 아프리카의 반려동물 의약품 시장 전망

제10장 남미의 반려동물 의약품 시장 전망

제11장 시장 역학

제12장 시장 동향과 발전

제13장 세계의 반려동물 의약품 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

제15장 경쟁 구도

제16장 전략적 제안

제17장 조사회사 소개·면책사항